[Influence of griseofulvin treatment on liver function and porphyrine metabolism].
D001219:Aspartate Aminotransferases / Q000097:blood; D004912:Erythrocytes / Q000032:analysis; D006118:Griseofulvin / Q000008:administration & dosage*; D006801:Humans; D007501:Iron / Q000097:blood; D008099:Liver / Q000187:drug effects* / Q000502:physiology / Q000503:physiopathology; D008111:Liver Function Tests; D008134:Long-Term Care; D014009:Onychomycosis / Q000188:drug therapy / Q000503:physiopathology; D010787:Photosensitivity Disorders; D011164:Porphyrias / Q000097:blood / Q000188:drug therapy / Q000652:urine; D011166:Porphyrins / Q000097:blood* / Q000652:urine; D013997:Time Factors
D011166:Porphyrins; D006118:Griseofulvin; D007501:Iron; D001219:Aspartate Aminotransferases
Der Einfluss der Griseofulvin-Therapie auf die Leberfunktion und den Porphyrin-Stoffwechsel.